Read More

Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report

Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility agreement for up to $175 million provided by Hercules Capital Inc.

ATAI

Read More

4Front Ventures Reports Financial Results: Accelerates Growth In Massachusetts And California

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF), a vertically integrated, multi-state cannabis operator and retailer, announced its financial results late Monday for the second quarter ended June 30, 2022.

CSE:FFNT